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Abstract
Background: Syndromic surveillance of severe acute respiratory infections (SARI) is important to assess seriousness
of disease as recommended by WHO for influenza. In 2015 the Robert Koch Institute (RKI) started to collaborate
with a private hospital network to develop a SARI surveillance system using case-based data on ICD-10 codes. This
first-time description of the system shows its application to the analysis of five influenza seasons.
Methods: Since week 40/2015, weekly updated anonymized data on discharged patients overall and on patients
with respiratory illness including ICD-10 codes of primary and secondary diagnoses are transferred from the
network data center to RKI. Retrospective datasets were also provided. Our descriptive analysis is based on data of
47 sentinel hospitals collected between weeks 1/2012 to 20/2016. We applied three different SARI case definitions
(CD) based on ICD-10 codes for discharge diagnoses of respiratory tract infections (J09 - J22): basic CD (BCD), using
only primary diagnoses; sensitive CD (SCD), using primary and secondary diagnoses; timely CD (TCD), using only
primary diagnoses of patients hospitalized up to one week. We compared the CD with regard to severity, age
distribution and timeliness and with results from the national primary care sentinel system.
Results: The 47 sentinel hospitals covered 3.6% of patients discharged from all German hospitals in 2013. The SCD
comprised 2.2 times patients as the BCD, and 3.6 times as many as the TCD. Time course of SARI cases
corresponded well to results from primary care surveillance and influenza virus circulation. The patients fulfilling the
TCD had been completely reported after 3 weeks, which was fastest among the CD. The proportion of SARI cases
among patients was highest in the youngest age group of below 5-year-olds. However, the age group 60 years and
above contributed most SARI cases. This was irrespective of the CD used.
Conclusions: In general, available data and the implemented reporting system are appropriate to provide timely
and reliable information on SARI in inpatients in Germany. Our ICD-10-based approach proved to be useful for
fulfilling requirements for SARI surveillance. The exploratory approach gave valuable insights in data structure and
emphasized the advantages of different CD.
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Background
Syndromic influenza surveillance in Germany is based on
a network of primary care physicians that report
consultations for acute respiratory infections (ARI) [1].
Weekly reports of ARI activity and corresponding results
from virological sentinel surveillance are published year-
round and data are sent to ECDC and WHO for inclusion
in the international influenza surveillance networks (EISN,
FluID, FluNet [2, 3]). This sentinel system (Working
Group Influenza/Arbeitsgemeinschaft Influenza (AGI))
has proven its value in providing timely and reliable infor-
mation on influenza activity in Germany and the burden
of disease, especially during the pandemic 2009 [4–6].
However, during the process of pandemic prepared-
ness planning and especially since the influenza pan-
demic 2009 the need to implement a routine sentinel
surveillance system for severe acute respiratory infec-
tions (SARI) became obvious [7, 8]. In the course of the
pandemic three ad hoc systems were established to cap-
ture severe respiratory cases. The first was the Pandemic
Hospital Based Surveillance (Pandemische Influenza
Krankenhaus-Surveillance (PIKS)) that was implemented
by the Robert Koch Institute (RKI) to collect data on
hospital admissions diagnosed with laboratory confirmed
influenza [9]. The second was a SARI-Surveillance study
that was part of a hospital-based pandemic influenza
vaccine effectiveness study [10]. Lastly, there was en-
hanced surveillance of influenza during the pandemic
with systematic collection of additional variables supple-
mentary to the national regular mandatory notifications
of laboratory confirmed influenza cases. For the
mandatory system, it was only possible to record infor-
mation on severity and risk factors according the WHO
recommendations as long as the pandemic was under
the scope of the Public Health Emergency of inter-
national Concern (PHEIC [11]) and an additional
national pandemic notification ordinance was in force
[12]. Although the information gathered on severe influ-
enza cases and risk factors for severe course of disease
were not only important in the national context but also
used for global analyses [13], none of the three ap-
proaches were continued on a routine basis. Thus, the
aim to establish a sustainable, timely and cost-efficient
approach that could collect data during seasonal influ-
enza epidemics and pandemics remained a priority.
The WHO recommends the national development of
SARI surveillance for hospital inpatients for influenza sur-
veillance. The approach combines a syndromic surveil-
lance part, where severe acute respiratory illness is
monitored, and a virological surveillance part, where all or
a systematically selected subset of patients were tested for
influenza [14]. While European countries have a long-
standing tradition of national outpatient syndromic influ-
enza surveillance systems, only a few have established
hospital inpatient SARI surveillance systems [15]. Other
European countries concentrate on laboratory-confirmed
influenza cases admitted to hospitals or intensive care
units only [2, 16].
The maintenance of continuous influenza surveillance
systems requires sufficient financial and personnel re-
sources. Therefore approaches using secondary data
offer an attractive possibility [17]. In 2015, the RKI set
up a research collaboration with a private network of
hospitals in order to develop a SARI sentinel surveil-
lance system. This used case-based data coded according
to the International Statistical Classification of Diseases
and Related Health Problems 10th Revision (ICD-10)
[18] and additional information on relevant procedures
such as ventilation. A similar approach was used previ-
ously in the German primary care syndromic sentinel
system to integrate case based ICD-10 coded reports.
This led to fundamental improvements as it provided
more detailed information on single ARI cases such as
age, sex and single respiratory diagnosis [19, 20].
We described the establishment of an ICD-10-based in-
patient syndromic sentinel system and its application to
the analysis of five influenza seasons. We compared the
impact of different case definitions on the ability to cap-
ture SARI cases, to allow a timely trend analysis of the
seasonal epidemic and to reflect the burden caused by in-
fluenza when compared to routine outpatient surveillance.
Methods
Description of the system
The syndromic SARI surveillance is based on anon-
ymized patient data originating from quality assurance
reports from hospitals belonging to the HELIOS Klini-
ken GmbH. The data use and reporting procedure was
approved by both the RKI and HELIOS Kliniken GmbH
data protection authority. As the study involved no
interventions and the analysis at RKI was based on
anonymized data only, no ethical clearance was required
in accordance with section 15 paragraph 1 of the
Professional Code for Physicians in Berlin, in accordance
with section 15 paragraph 1 of the Model Professional
Code for Physicians in Germany [21]. Therefore, data
use has not been discussed with an ethical committee. A
scientific cooperation agreement was put in place be-
tween the RKI and HELIOS Kliniken GmbH which set
out the data that was to be shared. Retrospective data-
sets for the years 2009 to 2014 were provided to the RKI
in August 2015. From season 2015/2016 (week 40/2015)
onwards, cumulative datasets containing data on all pa-
tients discharged were transferred via secure web service
from the HELIOS data center to RKI within two week-
days of a weekly cut-off date. Updated datasets were
then available for analyses the following day. These an-
nual datasets include data from 39 hospitals in 2009, 47
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hospitals in 2012 and 84 hospitals in 2016. Historical
and current data were stored on a SQL server with
restricted access only to a few selected members of the
Unit for Respiratory Infections at RKI.
The weekly updated data reports consist of two data
sets. The first dataset describes the total number of hos-
pitalizations within the reporting sentinel sites and con-
tains admission and discharge date, age (in years), sex
and the first two digits of the patient’s 5-digit post code
(indicates region and is usually able to identify the indi-
vidual German federal state) of every hospital inpatient.
This dataset also contains information on duration of
hospital stay, duration of stay in the intensive care unit
(ICU) and mode of discharge (discharged home, dis-
charged to other facility or deceased). The second data-
set describes the subset of patients with any respiratory
ICD-10 diagnosis code from chapter X (Diseases of the
respiratory system J00 - J99) recorded in their main or
secondary diagnosis. This second dataset also provide-
sinformation on admission diagnosis, on the primary
and all secondary discharge diagnoses, on duration of
ventilation, the first three digits of the patient’s 5-digit
post code, and the main department in hospital where
the patient received their care. A MD5 hash code was
used as an anonymous identifier in both datasets, which
enabled an evaluation of repeated stays of patients in the
same hospital but didn’t allow identification at RKI.
Study population and selection of diagnosis codes
Yearly datasets from 2012 onwards have been validated.
For the analysis in this paper we only included data from
the 47 hospital sites for which we had annual data for every
year in the period of week 1/2012–20/2016 in order to il-
lustrate the characteristics of our data over five consecutive
influenza seasons. This was last updated on 27 June 2016.
The number of patients covered by the sentinel sites were
compared to nationwide data from the federal statistical of-
fice of Germany regarding the number of hospitals and the
number of hospitalized patients in the years 2013 and 2014
[22, 23]. In the pilot phase several case definitions for SARI
syndrome based on combinations of ICD-10 J-codes [18] in
discharge diagnoses were selected after a literature research
(Appendix, [24–28]) and tested with regard to their sensi-
tivity for surveillance purposes (Fig. 1). Our dataset includes
patients with any primary and secondary ICD-10 diagnosis
code from J00 to J99. Thus, combinations of ICD-10 codes
containing codes from other chapters are not feasible (Ap-
pendix, [25, 27]). As the focus in syndromic influenza sur-
veillance is on acute respiratory diseases, we restricted
probable cases to ICD-10 diagnosis codes from J00 to J22
and excluded ICD-10 codes from J40 to J47, as they are
used for chronic lower respiratory diseases (Appendix,
[24]). We described the occurrence of the ICD-10 diagnosis
groups J00 - J06 (acute upper respiratory infections), J09 -
J18 (influenza and pneumonia) and J20–22 (other acute
lower respiratory infections) in the sentinel data and the
age distributions within the diagnosis groups. We defined
five age groups according to the outpatient sentinel system
(AGI) [5, 6], which were 0–4 years, 5–14 years, 35–59 years
and 60 years or older.
We subsequently chose to exclude the diagnosis group
for acute upper respiratory infections J00 - J06, as it does
not represent characteristics of severe disease and tends to
be associated with hospitalizations mainly in very young
children. In our data, 37% of the patients with primary
diagnosis J00 - J06 were under 3 years old (data not
shown). In the following text we defined SARI cases using
ICD-10 diagnosis codes J09 – J22. This case definition
aims to capture both the influenza-related pneumonias
and other influenza-related acute infections of the lower
respiratory tract [28]. An analogous selection of ICD-10
diagnosis codes has been described before [26].
As the diagnosis group J09 - J18 is the most relevant
for influenza surveillance, we split the group into J09 -
J11 (influenza) and J12 - J18 (pneumonia) and described
the occurrence of those groups and their age distribu-
tion. We graphically compared the subgroup of influenza
diagnoses (J09 - J11) with the much larger group of
acute lower respiratory diseases (J09 - J22).
To compare characteristics of case definitions, the
terms in-season and off-season were used. Weeks with
influenza activity (in-season) were defined according to
the criteria of the AGI (week 50/2012–16/2013, week 8/
2014–14/2014, week 2/2015–16/2015, week 2/2016–15/
2016), the remaining weeks were defined as off-season
[5, 6]. In order to differentiate increased proportions of
SARI cases supposedly due to intense transmission from
higher rates during holidays (potential artifacts), we ex-
amined the weeks of Christmas Holidays seperately in
our analysis. As the dates for the Christmas school
holidays varied among federal states, we defined weeks
including any of the national holidays such as the 24th
to 26th December, the 31th December and the 1st of
January as Christmas Holidays in this paper. Weekly
numbers of cases were calculated using the admission
date and the discharge diagnoses of patients.
Case definitions
Three different case definitions were developed.
We included patients containing any ICD-10 code of
the group J09 - J22 (SARI) in their primary discharge
diagnosis in our basic case definition (BCD).
In order to generate a highly sensitive estimate of the
burden of severe acute respiratory disease, we also gen-
erated a sensitive case definition (SCD). It comprised pa-
tients with any ICD-10 code of the group J09 - J22 in
their primary or secondary discharge diagnoses.
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A third case definition was used to maximize the timeli-
ness of information on SARI trends during the season. As
weekly data reports only include information on patients
who have been discharged, we restricted analysis to pa-
tients with hospital stays of one week duration or less.
Additionally, we only included patients with an ICD-10
code from the group J09 - J22 in the primary discharge
diagnosis, as these patients tended to be discharged within
a shorter time frame (timely case definition, TCD) (Fig. 1).
We illustrated time course and severity of recent influ-
enza seasons and showed characteristics in the three differ-
ent case definitions graphically. We calculated the weekly
proportions of hospitalizations, ICU admissions and deaths
associated with SARI separately for all three case definitions
and displayed the time trend of proportions graphically.
Proportions were calculated as described before [28].
In order to quantify the time lag in data with respect to
the three case definitions, we looked at cases with re-
ported admission date in week 6/2016. The reference
dataset used was the week 16/2016 at which point we as-
sumed that all patients would have been discharged.We
then analyzed the datasets from weeks 7/2016, 8/2016, 9/
2016 to calculate the percentage of reported cases with ad-
mission date from week 6/2016. This provided us with an
estimate of completeness of case ascertainment at 2, 3 and
4 weeks after admission.
We compared the course of the TCD with medically
attended acute respiratory infections in outpatients per
100,000 population per week (MAARI incidence) and
corresponding virological data generated in the German
primary care sentinel system (AGI) [6].
Maps were generated using RegioGraph Analyse 13;
StataSE 14, Microsoft Visio and Microsoft Excel were
used for other graphs and analyses.
Results
Distribution of sentinel hospitals and coverage of the
German population in the years 2013 and 2014
In 2013, the 47 sentinel sites included 2.4% of all hospitals
in Germany and were located in 13 of the 16 federal states.
There were no sentinel sites in the federal states of Bremen,
Fig. 1 Flow chart on data selection and generation of case definitions (data from week 1/2012–20/2016)
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Rhineland-Palatine and Saarland. In the year 2014, an add-
itional 35 sites became part of the sentinel network, thus
covering 4.2% of the German hospitals in 2014 (Fig. 2). The
sentinel hospitals accounted for 3.6% of all patients dis-
charged in any German hospital in 2013, and 5.9% in 2014
[18, 23]. However, only data from 47 hospitals contributing
since 2012 were used for the description of the system.
Study population and selection of ICD-10 discharge diag-
nosis groups for SARI
Of the patients admitted to the 47 hospitals during the
study period (week 1/2012–20/2016) 53% were 60 years
or older. However, this age group only accounted for 7%
of acute upper respiratory disease diagnoses (J00 - J06). In
this diagnosis group children, especially young children
below 5 years of age, comprised 45% of cases (Fig. 3).
The most relevant diagnosis groups for syndromic
surveillance of influenza and pneumonia are covered
by ICD-10 codes J09 – J11 (influenza) and J12 – J18
(pneumonia). The number of cases in the subgroup of
influenza diagnoses (J09 - J11) was small compared to
the number of cases in the group of pneumonia diag-
noses (J12 – J18). Age was distributed more evenly
for patients with a diagnosis of influenza (J09 - J11)
compared to other diagnostic groupings. There were
28% and 23% in the youngest and the oldest age
groups, respectively and 15% to 18% in all other age
groups. The group of pneumonia diagnoses (J12 -
J18) had a large proportion of elderly patients
(60 years and older) with 61%. Young children up to
4 years of age accounted for 18% of pneumonia diag-
nosis group (J12 - J18). When patients with the pri-
mary discharge diagnoses of influenza and pneumonia
(J09 – J18) were considered as a whole they had had
the same age distribution as the pneumonia group
(J12 – J18) due to the low numbers of the J09 – J11
group. In the diagnosis group of other acute lower re-
spiratory infections (IDC-10 codes J20 - J22) the
youngest and the oldest age groups contributed 40%
and 39%, respectively. In the study period, 54% of the
patients with ICD-10 codes J09 - J22 (SARI) in their
primary diagnosis were at least 60 years old, 25%
were less than 5 years old, and 12% were between 35
and 59 years old. This is the grouping that was ap-
plied for the basic case definition. The use of primary
diagnoses codes enables comparisons with health
Fig. 2 Regional distribution of sentinel sites in 2013 and in 2014
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statistics from other sources such as the Federal Stat-
istical Office in Germany.
The explicit in-season primary diagnoses of influenza
(J09 - J11) accounted for only 5% of SARI cases fulfilling
the basic case definition (Fig. 4). However, during and
following peak weeks of influenza seasons 2012/13
(weeks 7/2013–10/2013) and 2014/15 (weeks 8/2015–9/
2015), they constituted more than 10%, with a max-
imum proportion of 18% in the peak of season 2015/16
(week 9/2016). The proportion of influenza-diagnosed
patients was also higher in season 2015/16 compared to
the previous 4 seasons, and it exceeded 10% for 5 con-
secutive weeks (weeks 9/2016–13/2016). The propor-
tion of influenza diagnoses among cases meeting the
BCD was very low in the seasons 2011/12 and 2013/14
with a maximum rate of 2% influenza diagnoses (J09–
11) among all J09–22 primary discharge diagnoses. Off-
season influenza diagnoses (J09 - J11) were very rare
with a mean proportion of 0.6% in the acute lower re-
spiratory diseases group (J09–22).
Fig. 3 Age distribution of patients overall and for different ICD-10 diagnosis groups in weeks 1/2012–20/2016
Fig. 4 Number of patients with ICD-10 codes J09 - J22 (influenza, pneumonia and other acute lower respiratory infections (BCD), left y-axis) and patients
with ICD-10 codes J09 - J11 (influenza, right y-axis) in primary diagnosis per week in 47 sentinel sites from week 1/2012–20/2016, in-season weeks are
highlighted in grey color
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Comparison of case definitions
After descriptive exploration of different ICD-10 code
groups we selected ICD-10 codes J09–22 for retrospective
analysis of SARI cases using the three different case defini-
tions, as defined in the methods section. In order to cap-
ture all SARI cases per week in the sentinel hospitals and
to estimate the burden of disease, we applied the SCD.
The sensitivity of this case definition was higher than for
the BCD as it includes not only patients with primary dis-
charge diagnosis from J09 - J22, but also cases with any
secondary discharge diagnosis from J09 - J22 (Fig. 5).
Comparison of total numbers of cases identified using
each of the case definitions showed that the SCD identified
twice as many SARI cases as the BCD and nearly four times
as many SARI cases as the TCD (also see Fig. 1). However,
seasonality became less obvious when the SCD (any pri-
mary or secondary discharge diagnoses from J09 - J22) was
applied as compared to the BCD (only primary discharge
diagnosis from J09 - J22).
Weekly proportions of hospitalizations, ICU admissions
and deaths associated with SARI cases were compared in
order to assess the impact and the severity of a season
using the different case definitions [28]. The weekly num-
ber of all patients hospitalized in the 47 sentinel hospitals
fluctuated markedly in the weeks at the end of the year. In
weeks outside the Christmas Holidays, a median of 12,934
patients per week were hospitalized (range: 10,327–14,423
patients per week). During Christmas holidays, the me-
dian number of admitted patients per week fell to 8054
(range: 6697–9999 patients per week).
The median proportion of patients per week fulfilling
the SCD among all hospitalized Patients was 4% off-
season and 6% in-season with peaks of up to 11% during
Christmas holidays and during the influenza season (Fig.
6a). Among patients admitted to the intensive care unit
(ICU) during their hospital stay, a median of 10% fulfilled
the SCD in the off-season rising to 13% during the influ-
enza season. Peaks up to 17% were observed during the
influenza season and Christmas holidays. The proportion
of SCD patients among deceased was much more variable
over the year, since the numbers were much smaller per
week. The median proportion of cases per week among
deceased was 26% in the off-season and 29% in-season
and during Christmas holidays. It ranged from 17% to a
maximum of 38% in the 2014/15 influenza epidemic.
The median proportion of patients fulfilling the BCD
however was 2% for both all inpatients and those admit-
ted to the ICU (Fig. 6b). Similar to the proportion of
SCD, there were peaks during holidays and during the
influenza season. In contrast, the median proportion of
BCD among deceased patients was higher compared to
the overall proportion of cases among all patients. It was
4%, ranging from 1% to 9% in the off-season, and 6%
ranging from 3% to 12% during the influenza season
with two distinct peaks in the strong influenza seasons
of 2012/13 and 2014/15.
The proportions of patients fulfilling the BCD and TCD
for the groupings of: all patients, patients admitted to ICU
and deceased; followed a similar pattern over time (Fig. 6b
and c). However, a smaller proportion of patients fulfilled the
TCD compared to the BCD in the groupings: all patients,
patients admitted to ICU and deceased patients. The propor-
tion of patients fulfilling the TCD was particularly low for pa-
tients in ICU where patient stays are likely to be longer due
to greater illness severity thus exceeding the time restriction.
With the implementation of weekly data reporting in
the 2015/16 surveillance we were able to examine the
data for time lags in reporting. In the data from week 1/
Fig. 5 Number of SARI cases with ICD-10 codes J09 - J22 in primary diagnosis (basic case definition, BCD), in secondary diagnosis and in main or
secondary diagnosis (sensitive case definition, SCD) per week in 47 sentinel sites from week 1/2012–20/2016
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2012 to week 20/2016, 99% of the SCD were hospitalized
for less than 64 days, which was a little more than
9 weeks. In contrast to that, 99% of the BCD had been
released after only 33 days of hospitalization. This meant
that reporting on cases hospitalized in a specific week
was nearly complete after 10 weeks.
Fig. 6 a, b, c Proportion of hospitalized patients, hospitalized patients admitted to ICU and hospitalized deceased patients fulfilling the sensitive
case definition (SCD, a), basic case definition (BCD, b) or timely case definition (TCD, c) per week in 47 sentinel sites from week 1/2012–20/2016,
in-season weeks are highlighted in grey color
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Using the admission week 6/2016 we found that
within 2 weeks (week 8/2016) 62% of the BCD and 83%
of the TCD had been reported (Table 1). A smaller pro-
portion, 45% of cases fulfilling the SCD, had been reported
by this timepoint. As the TCD had restrictions on the
hospitalization time (less than 8 days), we had the
complete report on cases after 3 weeks. However, data
reported only one week (week 7/2016) after week 6/2016
included less than 8% of the cases compared to the refer-
ence dataset (week 16/2016) for all case definitions.
The TCD was compared to the weekly primary care
sentinel data on ARI activity within the influenza season in
order to evaluate whether it was sufficiently sensitiveto
detect changes and peaks in seasonal activity. The peaks in
the trend of the TCD matched the time course of the
MAARI incidence and the corresponding influenza-positive
samples generated by primary care data very well (Fig. 7).
The MAARI incidence sloped earlier, around week 40, and
had a drop at the end of the year during the Christmas
holidays. The inpatient data showed no such rise in autumn,
but had a small peak during the Christmas holidays.
Differences in CD in age, sex, severity level and length of stay
The difference between CD regarding the proportion of
SARI cases among all hospitalized patients in different
age groups and the proportion of males among SARI
cases was presented in Table 2. The proportion of SARI
cases was highest in the youngest age group (0–4 years)
for all CD. The proportion of SARI cases in the elderly
age group (60 years and more) was much higher when
applying the SCD.
Age-grouped proportions of SARI cases that received
ICU treatment, ventilation or had a fatal outcome were
presented in Table 3 for the three case definitions. SARI
cases fulfilling the SCD had a much higher proportion of
severe and fatal outcome. Especially in SARI cases of the
two highest age groups, the severe outcome was more
pronounced compared to the younger age groups irre-
spective of the CD used. The proportion of fatal outcomes
was especially high in the age group of 60 years and older
across all groups. The median duration of stay varied with
age and level of care (ICU, ventilation) (Table 4).
Discussion
Our analyses of data on SARI cases demonstrated the
potential of the newly established syndromic hospital
surveillance system. For the first time it was possible to
show the number and proportion of SARI cases in
hospital as a time series over five subsequent influenza
seasons in Germany. The temporal pattern of hospital-
ized SARI patients in sentinel data corresponded well to
the course of the MAARI incidence and the virological
results of the German outpatient sentinel (AGI). The
earlier rise of the MAARI incidence in autumn com-
pared to SARI case frequency can be attributed to
Rhinovirus circulation in this time of the year, as had
been shown in the seasonal influenza reports from the
primary care sentinel surveillance (AGI [5]).
As the aim of this study was to establish a robust sus-
tainable SARI surveillance system, we not only tested
different diagnosis groups in order to determine an opti-
mal combination of ICD-10 codes from chapter J, but
also different diagnosis classes (admission or discharge;
primary or secondary) and time restrictions in the length
of stay. We found that no single case definition is able
to meet all our surveillance requirements optimally, as
had been discussed before [29].
We were able to show that a very specific selection of
ICD-10 codes including only patients with primary diag-
nosis J09 to J11 is not suitable for surveillance purposes
by itself. Mild influenza seasons such as 2013/14 would
not have been detected using this definition. This disad-
vantage cannot be adjusted by an additional inclusion of
patients with secondary diagnosis J09 to J11 (data not
shown). As there are no specific recommendations for in-
fluenza diagnostic in Germany, it is up to the attending
physician to decide if a patient with acute respiratory
symptoms will be tested for influenza. By using only ICD-
10 codes J09–11 the overwhelming proportion of influ-
enza and influenza-related illness of the lower respiratory
tract will be missed due to testing bias. Therefore, we used
an ICD-10 grouping that captures both the influenza-
related pneumonias and other influenza-related acute in-
fections of the lower respiratory tract as recommended for
syndromic influenza surveillance [14, 28].
The basic case definition (BCD) using only primary dis-
charge diagnoses of acute lower respiratory infections (J09
– J22) is the only CD that can be used for comparisons with
other health statistics of hospitalized patients both nation-
ally and internationally. But using only primary diagnoses
captures mainly the population without major comorbidi-
ties. Therefore, a more sensitive case definition (SCD) was
found to be more appropriate in terms of estimating disease
Table 1 Completeness of data on cases hospitalized in week 6/















35 (5%) 53 (3%) 35 (7%)
Data of week
8/2016
464 (62%) 694 (45%) 419 (83%)
Data of week
9/2016
671 (89%) 1142 (75%) 503 (100%)
Data of week
16/2016
750 (100%) 1530 (100%) 503 (100%)
Data report of week 16/2016 was the reference dataset
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burden. SARI patients with an underlying chronic dis-
ease such as heart disease or chronic respiratory dis-
ease may have their comorbidity coded in the primary
diagnosis and the acute respiratory disease in their
secondary diagnosis, as the aggravation of the chronic
disease could play a major role in their hospitalization
[30]. This means that an after-season assessment of
severity and burden could be used to compare BCD
and SCD in order to provide additional information
on the populations most affected.
The SCD is not suitable for in-season surveillance
of SARI activity, as patients with underlying diseases
tend to have a more extended stays in hospital and
their data is available later than data of patients with
no or only minor illnesses apart from their acute re-
spiratory disease. The subset of SARI patients fulfill-
ing the BCD with a length of stay <8 days i.e.
meeting the timely case definition (TCD) were used
to assess the trend of acute respiratory activity. The
TCD data lags two weeks behind the information
from primary care sentinal surveillance (AGI), but
still allows a timely situation assessment within the
season.
Ideally this information would be available even earl-
ier by using the admission diagnosis while patients are
still hospitalized. It was not possible to establish this at
the beginning of the project. However, about two-thirds
of SARI patients fulfilling the BCD at discharge also had
an admission diagnosis code from J09 - J22 . This pro-
portion remained relatively stable throughout the study
period (data not shown). Using the admission diagnosis
with the diagnosis codes we selected (J09 - J22) would
enable a nearly real-time hospital surveillance in the fu-
ture [14, 28].
The available data set allowed an exploratory approach
and provided additional information, also on potential
country-specific issues like changing hospitalization rates
over the Christmas period. Many primary care practices
are closed during the holidays and patients with acute ill-
ness tend to go to hospital directly while planned surgeries
and examinations in hospitals are postponed. Our findings
of consistently higher hospitalization rates over the Christ-
mas holidays might be valuable in the interpretation of
the data in future epidemics as they might lead to over-
estimation of the burden of acute respiratory disease at
this time of the year.
Fig. 7 Number of SARI patients with ICD-10 codes J09 - J22 in primary diagnosis and hospitalization 1 week or less (timely case definition, TCD)
per week in 47 ICOSARI sentinel sites, MAARI incidence (scaled to 15% of its value) and number of influenza-positive AGI sentinel samples from
outpatients, week 1/2012–20/2016
Table 2 Proportion of SARI cases among total hospitalizations and proportions of male cases among SARI cases using different case
definitions in 5 age groups and over all age groups in weeks 1/2012–20/2016
% SARI cases among all hospitalized patients % male cases among SARI cases
Case definition < 5 5–14 15–34 35–59 60+ all < 5 5–14 15–34 35–59 60+ all
BCD 8.3 2.9 0.8 1.1 2.2 2.2 58.7 53.0 52.9 56.1 53.5 55.1
SCD 9.5 3.6 1.5 2.7 6.3 4.9 58.9 53.8 52.1 60.5 55.1 56.2
TCD 7.2 2.5 0.7 0.7 1.1 1.4 58.6 53.8 51.8 54.5 54.0 55.5
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We included additional information, such as the
duration of stay in normal wards, ICU and the dur-
ation of ventilation by age group. This has been
shown to provide valuable information on the impact
of the secondary health care level during severe influ-
enza seasons [31, 32]. The proportion of SARI cases
with fatal outcome in the severe influenza A (H3N2)-
dominated 2014/15 season corresponded well with
the results of the estimated excess mortality in other
European countries [33].
Only a very small fraction of hospitalized patients
with acute respiratory symptoms are tested for labora-
tory confirmation of influenza in Germany [9]. This
may have different reasons. Firstly, onset of disease
starts several days before the symptoms get worse
and family doctors refer patients to hospital. At this
point secondary bacterial infection may have become
the focus of diagnostic and treatment and influenza
viruses can no longer be identified [34, 35]. Secondly,
clinical influenza diagnosis as selection criterion for
laboratory confirmation may only detect patients that
display typical influenza-like-illness. Fever as a princi-
pal symptom loses its significance especially in elderly
patients [36–38]. Thirdly, 75% of community acquired
pneumonia is diagnosed and ICD-10-coded without
identification of a causative pathogen in Germany
(J18.-) [39].
For these reasons we decided to adopt the surveil-
lance recommendations of the WHO [14] for a sensi-
tive SARI case definition. A comparable sensitive
ICD-10-based ARI case definition was implemented
successfully in the primary care syndromic surveil-
lance [5, 20]. However, specific and representative in-
formation on influenza virus circulation is absolutely
necessary for the interpretation of the data according
to the impact of influenza on SARI cases. Therefore
the results of the national virological sentinel surveil-
lance of the primary care sentinel (AGI) are relayed
on a daily basis from the National Influenza Refer-
ence Center (NIRC) to the epidemiological influenza
database of our unit at the RKI [5].
One of the most important limitations of our ap-
proach was the current lack of complementary viro-
logical information, with testing of at least a
representative subset of the identified SARI patients,
as recommended by the WHO [14]. Where an inves-
tigation specifically focusses on laboratory confirmed
influenza, we could restrict our analysis to patients
with ICD-10 diagnoses J09 and J10 (Influenza due to
identified influenza virus). However, a complementary
virological inpatient surveillance system could be
established in the future.
Conclusions
We were able to show that the available data and report-
ing procedures implemented, provided timely and reliable
information on SARI in inpatients in Germany. The ex-
ploratory approach gave valuable insights into the data
structure, showed the importance of using different case
definitions tailored to the objectives of the evaluation, and
allowed the adaptation of our country specific data
sources according to international recommendations.
Based on the five seasons analyzed we were able to create
a SARI baseline as a starting point for evaluation of sever-
ity of future influenza epidemics or pandemics. At the
same time, the newly established system will allow an even
more detailed analysis focusing on different subgroups of
patients with specific risk factors and underlying
conditions.
Table 3 Proportions of ICU treatment, ventilation and deceased among SARI cases using different case definitions in 5 age groups
and over all age groups in weeks 1/2012–20/2016
% SARI cases with ICU treatment % ventilated among SARI cases % deceased among SARI cases
Case definition < 5 5–14 15–34 35–59 60+ all < 5 5–14 15–34 35–59 60+ all < 5 5–14 15–34 35–59 60+ all
BCD 4.6 5.9 7.5 13.9 17.1 12.7 1.3 3.0 2.9 5.8 6.9 5.0 0.02 0.07 0.3 1.5 8.0 4.5
SCD 6.0 8.2 19.6 36.1 38.4 32.6 2.1 3.8 9.3 19.3 17.4 15.1 0.08 0.14 1.7 7.6 15.1 11.3
TCD 2.7 2.9 5.0 8.2 11.1 7.0 0.5 1.2 1.2 2.5 3.7 2.1 0.01 0.04 0.2 1.6 10.2 4.4
Table 4 Median duration of hospitalization, ICU treatment and ventilation among affected SARI cases using different case definitions
in 5 age groups and over all age groups in weeks 1/2012–20/2016
Median duration of stay (days)
for SARI cases
Median duration in ICU (days)
for SARI cases with ICU treatment
Median duration of ventilation (hours)
for ventilated SARI cases
Case definition < 5 5–14 15–34 35–59 60+ all < 5 5–14 15–34 35–59 60+ all < 5 5–14 15–34 35–59 60+ all
BCD 4 4 4 6 8 6 3 4 3 3 3 3 100 140.5 78 74 61 69
SCD 4 4 5 8 10 8 3 4 4 5 4 4 118 143 128.5 142 95 104
TCD 4 4 3 4 5 4 2 3 1 1 1 2 44 117 47 41.5 32 37
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